Surgical Approach in Congenital Long QT Interval Syndrome Patients

1. Bohnen MS, Peng G, Robey SH, et al. Molecular Pathophysiology of Congenital Long QT Syndrome. Physiol Rev. 2017;97(1):89–134. doi: 10.1152/physrev.00008.2016553937227807201Open DOISearch in Google Scholar

2. Van Niekerk C, Van Deventer BS, Du Toit–Prinsloo L. Long QT syndrome and sudden unexpected infant death. J Clin Pathol. 2017;70(9):808–813. doi: 10.1136/jclinpath–2016–204199Open DOISearch in Google Scholar

3. Schwartz PJ, Stramba–Badiale M, Crotti L, et al. Prevalence of the congenital long–QT syndrome. Circulation. 2009;120(18):1761–1767. doi: 10.1161/CIRCULATIONAHA.109.863209278414319841298Open DOISearch in Google Scholar

4. Neira V, Enriquez A, Simpson C, Baranchuk A. Update on long QT syndrome. J Cardiovasc Electrophysiol. 2019. doi: 10.1111/jce.1422731596038Open DOISearch in Google Scholar

5. Wallace E, Howard L, Liu M, et al. Long QT Syndrome: Genetics and Future Perspective. Pediatr Cardiol. 2019;40(7):1419–1430. doi: 10.1007/s00246–019–02151–xOpen DOISearch in Google Scholar

6. Antonopoulos A, Lawrence D, Patrini D, et al. The role of sympathectomy in long QT syndrome. J Thorac Dis. 2017;9(9):3394–3397. doi: 10.21037/jtd.2017.08.45570844329221324Open DOISearch in Google Scholar

7. Johnson JN, Ackerman MJ. QTc: how long is too long? Br J Sports Med. 2009;43(9):657–662. doi: 10.1136/bjsm.2008.054734394006919734499Open DOISearch in Google Scholar

8. Cardiac Health. Long QT Syndrome (Figuur). Card Heal. 2017:1524–1529. doi: 10.1161/CIRCULATIONAHA.113.00398524709866Open DOISearch in Google Scholar

9. Schwartz PJ, Crotti L, Insolia R. Long–QT syndrome from genetics to management. Circ Arrhythmia Electrophysiol. 2012;5(4):868–877. doi: 10.1161/CIRCEP.111.962019346149722895603Open DOISearch in Google Scholar

10. Shah M, Carter C. Long QT syndrome: A therapeutic challenge. Ann Pediatr Cardiol. 2008;1(1):18–26. doi: 10.4103/0974–2069.41051Open DOISearch in Google Scholar

11. Manuscript A. NIH Public Access. 2010;7(12):1806–1807. doi: 10.1016/j.hrthm.2010.09.075.EditorialOpen DOISearch in Google Scholar

12. Gepstein L, Boulous M. Specific Therapy Based on the Genotype in a Malignant Form of Long QT3, Carrying the V411M Mutation. 2019:979–982. doi: 10.1536/ihj.18–705Open DOISearch in Google Scholar

13. Priori SG, Blomstrom–Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–2867l. doi: 10.1093/eurheartj/ehv31626320108Open DOISearch in Google Scholar

14. Callans DJ. 2017 AHA / ACC / HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death : Executive Summary. 2018;72(14). doi: 10.1016/j.jacc.2017.10.05329097294Open DOISearch in Google Scholar

15. Chockalingam P, Crotti L, Girardengo G, et al. Not All Beta–Blockers Are Equal in the Management of Long QT Syndrome Types 1 and 2 Higher Recurrence of Events Under Metoprolol. JAC. 2012;60(20):2092–2099. doi: 10.1016/j.jacc.2012.07.046351577923083782Open DOISearch in Google Scholar

16. Mazzanti A, Maragna R, Vacanti G, et al. Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome. J Am Coll Cardiol. 2018;71(15):1663 LP – 1671. doi: 10.1016/j.jacc.2018.01.07829650123Open DOISearch in Google Scholar

17. Cho Y. Management of Patients with Long QT Syndrome. Korean Circ J. 2016;46(6):747–752. doi: 10.4070/kcj.2016.46.6.747509932727826330Open DOISearch in Google Scholar

18. Priori SG, Salvatore Maugeri F, Wilde AA, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes STATES Representative for American College of Cardiology Representative for American Heart Association Representative for Pediatric and Congenital Electrophysiology Society * Representative for Association for European Pediatric and Congenital Cardiology. 2013. https://www.escardio.org/static_file/Escardio/Press–media/press–releases/2013/diagnosis–management–patients–inherited–primary–arrhythmia–syndromes.pdf.10.1016/j.hrthm.2013.05.01424011539Search in Google Scholar

19. Coyer BH, Pryor R, Kirsch WM, Blount SG. Left stellectomy in the long QT syndrome. Chest. 1978;74(5):584–586. doi: 10.1378/chest.74.5.584738103Open DOISearch in Google Scholar

20. Cho Y. Left cardiac sympathetic denervation: An important treatment option for patients with hereditary ventricular arrhythmias. J arrhythmia. 2016;32(5):340–343. doi: 10.1016/j.joa.2015.08.002506326727761156Open DOISearch in Google Scholar

21. Wung PK, Wigley FM. Sympathectomy Learn more about Sympathectomy Management of Systemic Sclerosis and Raynaud ’ s Phenomenon RAYNAUD PHENOMENON AND VA–SOMOTOR SYNDROMES Raynaud Phenomenon and Vasomotor Syndromes. 2017.Search in Google Scholar

22. Bos JM, Bos KM, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation in long QT syndrome: Analysis of therapeutic nonresponders. Circ Arrhythmia Electrophysiol. 2013;6(4):705–711. doi: 10.1161/CIRCEP.113.00010223728945Open DOISearch in Google Scholar

23. Téllez LJ, Garzón JC, Vinck EE, Castellanos JD. Video–assisted thoracoscopic cardiac denervation of refractory ventricular arrhythmias and electrical storms: a single–center series. J Cardiothorac Surg. 2019;14(1):17. doi: 10.1186/s13019–019–0838–6Open DOISearch in Google Scholar

24. Schwartz PJ, Priori SG, Cerrone M, et al. Left Cardiac Sympathetic Denervation in the Management of High–Risk Patients Affected by the Long–QT Syndrome. Circulation. 2004;109(15):1826–1833. doi: 10.1161/01.CIR.0000125523.14403.1E15051644Open DOISearch in Google Scholar

25. Costello JP, Wilson JK, Louis C, et al. Surgical cardiac denervation therapy for treatment of congenital ion channelopathies in pediatric patients: a contemporary, single institutional experience. World J Pediatr Congenit Heart Surg. 2015;6(1):33–38. doi: http://dx.doi.org/10.1177/215013511455520310.1177/215013511455520325548341Search in Google Scholar

26. Jang SY, Cho Y, Kim NK, et al. Video–Assisted Thoracoscopic Left Cardiac Sympathetic Denervation in Patients with Hereditary Ventricular Arrhythmias. PACE – Pacing Clin Electrophysiol. 2017;40(3):232–241. doi: 10.1111/pace.1300828012188Open DOISearch in Google Scholar

27. Waddell–Smith KE, Ertresvaag KN, Li J, et al. Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long–QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia. Circ Arrhythmia Electrophysiol. 2015;8(5):1151–1158. doi: 10.1161/CIRCEP.115.00315926224781Open DOISearch in Google Scholar

28. Hwang SW, Thomas JG, Whitehead WE, et al. Left thorascopic sympathectomy for refractory long QT syndrome in children. J Neurosurg Pediatr PED. 2011;8(5):455–459. doi: 10.3171/2011.8.PEDS1116422044368Open DOISearch in Google Scholar

29. Haranal MY, Simha P, Shenthar J, Rajasekharappa R. High thoracic left sympathectomy for recalcitrant ventricular tachyarrhythmias and long QT syndrome. Indian J Thorac Cardiovasc Surg. 2018;34(2):103–108. doi: 10.1007/s12055–017–0548–4Open DOISearch in Google Scholar

30. Ackerman, M. J. & Schwartz, P. J. Congenital long QT syndrome: Pathophysiology and genetics. UpTo Date 1–29 (2019).Search in Google Scholar

31. Van Noord, C., Eijgelsheim, M. & Stricker, B. H. C. Drug– and non–drug–associated QT interval prolongation. Br. J. Clin. Pharmacol.70, 16–23 (2010).Search in Google Scholar

32. Northrup H, Koenig MK, Pearson DA, Au KS. Long QT Syndrome. 2018:1–36. https://www.ncbi.nlm.nih.gov/books/.Search in Google Scholar

33. A. Pelliccia et al., “Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of My,” Eur. Heart J., vol. 26, no. 14, pp. 1422–1445, 2005.Search in Google Scholar

34. D. J. Tester, P. J. Schwartz, and M. J. Ackerman, “Congenital long QT syndrome,” Electr. Dis. Hear. Vol. 1 Basic Found. Prim. Electr. Dis., pp. 439–468, 2013.10.1007/978-1-4471-4881-4_27Search in Google Scholar

35. M. J. Ackerman, D. P. Zipes, R. J. Kovacs, and B. J. Maron, “Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement from the American Heart Association and American College of Cardiology,” J. Am. Coll. Cardiol., vol. 66, no. 21, pp. 2424–2428, 2015.Search in Google Scholar

36. A. J. Moss et al., “Effectiveness and limitations of β–blocker therapy in congenital long–QT syndrome,” Circulation, vol. 101, no. 6, pp. 616–623, 2000.10.1161/01.CIR.101.6.61610673253Search in Google Scholar

37. A. Barsheshet, O. Dotsenko, and I. Goldenberg, “Genotype–specific risk stratification and management of patients with long QT syndrome,” Ann. Noninvasive Electrocardiol., vol. 18, no. 6, pp. 499–509, 2013.10.1111/anec.12117693257424206565Search in Google Scholar